encompasses urological product/technologies, genital/reproductive medicine
The worldwide high energy therapies market represents a $25 billion opportunity in 2008. The category consists of therapeutic devices and equipment that deliver the controlled application of one or more modalities of energy to tissue.
This market will grow at a compound annual growth rate of 11% with some modalities exceeding a 20% CAGR.
The global market [...]
Technologies for ablation and other energy-based treatments in medical/surgical markets are currently dominated by electrosurgical-type therapies, but a growing array of other modalities are creating new applications or penetrating existing ones.
At right is shown the forecast, by modality type, of ablation and other energy-based therapies through 2017. The most significant growth is expected to [...]
(See forthcoming report #A125, “Ablation Technologies Worldwide Market, 2008-2017,” from MedMarket Diligence, LLC. May be purchased online.)
Energy-based therapies generate sales of $13 billion in the United States alone, with probably another $12 billion in other developed markets worldwide. This represents around 13% of the total medical device market, and it is growing at 11% per [...]
Below is the coverage in the April 2008 issue of MedMarkets.
Ablation: An Energized Market
Demand for Hip and Knee Implants Expected to Increase
MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends
Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular
Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, IDev Technologies, IlluminOss [...]
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing.
As all white papers should be, it’s free. Here’s the link so you can download it.
bookmark to
New companies in the medical technology industry are pursuing technologies to make existing technologies obsolete, expand existing markets, create new markets and otherwise tap into demand for new solutions in healthcare.
The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in the Startups coverage in the [...]
Not every start-up succeeds. But every single successful medical technology company was once a start-up. From a primary consideration, start-up companies have been founded based on: (1) what technologies they consider possible, and (2) the need for clinical solutions to problems that exist in health care. For this reason, we look at the range of [...]
The terms “sealant” and “glue” tend to be used interchangeably in the surgical context, but in fact there is a difference in adhesive strength between sealants, pioneered by fibrin products (sometimes homemade) and the later, stronger glues of which cyanoacrylate-based products were the leaders.
Fibrin sealants represented a revolution in local hemostatic measures for both bleeding [...]
Bulking Agents for Stress UI
One important weapon in the arsenal of noninvasive or minimally invasive therapies for Stress Urinary Incontinence (SUI) comprises bulking agents—injectable substances that expand the intrinsic sphincter of the bladder, allowing it to withstand greater pressures.
There are several companies exploring or developing bulking agents for SUI (see chart). For many of these, [...]
Company Steadily Secures the Urogenital Treatment Market
The acquisition of Laserscope by American Medical Systems Holdings this month for $715 million adds a certain punctuation to AMSH’s steadily growing presence in the field of urogenital medicine or, as the company refers to it, “pelvic health.” Lest there be any doubt, AMSH has been on a Tyco-like [...]